Characterization of thyroid-stimulating blocking antibodies that appeared during transient hypothyroidism after radioactive iodine therapy

Thyroid

Volumn 10, Issue 10, 2000, Pages 909-917

  Kung, A W C ^a   Lau, K S ^a   Kohn, L D ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCKING ANTIBODY; CHORIONIC GONADOTROPIN RECEPTOR; CYCLIC AMP; IMMUNOGLOBULIN G; LUTEINIZING HORMONE; RADIOACTIVE IODINE; THYROTROPIN; THYROTROPIN RECEPTOR;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CHIMERA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; EPITOPE MAPPING; FEMALE; GENETIC TRANSFECTION; GRAVES DISEASE; HAMSTER; HUMAN; HUMAN CELL; HYPOTHYROIDISM; MALE; ONSET AGE; PRIORITY JOURNAL; THYROID WEIGHT; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT OUTCOME;

EID: 0033769016     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2000.10.909     Document Type: Article

References (24)

1. Rising incidence of hypothyroidism after radioactive iodine therapy in thyrotoxicosis
2. 131I therapy for hyperthyroidism in relation to immunologic parameters
3. Transient hypothyroidism following radioiodine therapy thyrotoxicosis
4. Thyrotropin receptor epitopes recognized by Graves' autoantibodies developing under immunosuppressive therapy
5. Two Graves' disease patients who spontaneously developed hypothyroidism after antithyroid drug treatment: Characteristics of epitopes for thyrotropin receptor antibodies
6. Effect of irradiation on thyroid-autoantibody production
7. Effect of radioiodine on stimulatory activity of Graves' Immunoglobulins
8. Specific effects of radioiodine treatment on TSAb and TBAb levels in patients with Graves' disease
9. Immunoglobulins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients
10. Epitopes for thyroid stimulating antibodies in Graves' sera: A possible link of heterogeneity to differences in response to antithyroid drug treatment
11. Changes in epitopes for thyroid stimulating antibodies in Graves' disease sera during treatment of hyperthyroidism: Therapeutic implications
12. Characterization of monoclonal thyroid stimulating and thyrotropin binding inhibiting autoantibodies from a Hashimoto's patient whose children had intrauterine and neonatal thyroid disease
13. Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor
14. Subtypes of anti-TSH receptor antibodies classified by bio- and conversion assays using CHO cells expressing wild type human TSH receptor or TSH receptor-LH/CG receptor chimera
15. Two Graves' disease patients who spontaneously developed hypothyroidism after antithyroid drug treatment: Characteristics of epitopes for thyrotropin receptor antibodies
16. Graves' immunoglobulins activate phospholipase A2 by recognizing specific epitopes on the TSH receptor
17. Epitope heterogeneity of TSH blocking antibodies in Graves' patients as detected with wild type versus chimeric TSH receptors
18. The incidence of ophthalmopathy after radioiodine therapy for Graves' disease - Prognostic factors and the role of methimazole
19. Treatment of thyrotoxicosis with radioactive iodine - Review a 140 cases
20. Thyroid gland weight determination from thyroid scintigram with postmortem verification
21. Long-term results from graded low dose radioactive iodine therapy for thyrotoxicosis
22. Differences and similarities in the diagnosis and treatment of Graves' Disease in Europe, Japan and the United States
23. Outcome of thyroid function in Graves' patients treated with radioiodine: Role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage
24. 131I treatment for Graves' disease